CRISPR Therapeutics AG's top three insider shareholders as of March 23, 2026 are Simeon George (Director, 1.73Mn shares), Rodger Novak (President, 573.01K shares), Samarth Kulkarni (Chief Executive Officer, 226.11K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Simeon George | 0 | 1,730,179 | 17 Jul, 2025 | |
| Rodger Novak | President | 573,007 | 0 | 01 Jul, 2021 |
| Samarth Kulkarni | Chief Executive Officer | 245,834 | 0 | 17 Mar, 2026 |
| James R. Kasinger | General Counsel And Secretary | 91,240 | 0 | 17 Mar, 2026 |
| Tony W Ho | Executive Vp, Head Of Rd | 52,364 | 0 | 07 Dec, 2021 |
| Lawrence Otto Klein | Cbo Coo | 26,797 | 0 | 14 Mar, 2022 |
| Douglas A Treco | 22,000 | 0 | 08 Aug, 2025 | |
| Naimish Patel | Chief Medical Officer | 13,143 | 0 | 17 Mar, 2026 |
| Raju Prasad | Chief Financial Officer | 13,023 | 0 | 17 Mar, 2026 |
| John Greene | 7,000 | 0 | 28 Feb, 2025 | |
| Brendan Smith | Chief Financial Officer | 5,072 | 0 | 22 Feb, 2023 |
| Phuong Khanh Morrow | Chief Medical Officer | 4,411 | 0 | 25 May, 2023 |
| Michael John Tomsicek | Chief Financial Officer | 1,891 | 0 | 10 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Mar, 2026 | James R. Kasinger | Common Shares | A | 6,875 | - | 94,690 | D | M |
| 14 Mar, 2026 | Samarth Kulkarni | Common Shares | A | 20,625 | - | 256,183 | D | M |
| 14 Mar, 2026 | Raju Prasad | Common Shares | A | 10,000 | - | 16,767 | D | M |
| 14 Mar, 2026 | Naimish Patel | Common Shares | A | 8,125 | - | 16,293 | D | M |
| 16 Mar, 2026 | James R. Kasinger | Common Shares | D | 3,450 | $48.26 | 91,240 | D | S |
| 14 Mar, 2026 | Raju Prasad | Common Shares | A | 6,875 | - | 23,642 | D | M |
| 16 Mar, 2026 | Samarth Kulkarni | Common Shares | D | 10,349 | $48.26 | 245,834 | D | S |
| 16 Mar, 2026 | Naimish Patel | Common Shares | D | 3,150 | $48.26 | 13,143 | D | S |
| 14 Mar, 2026 | Samarth Kulkarni | Restricted Stock Units | D | 20,625 | - | 61,875 | D | M |
| 14 Mar, 2026 | James R. Kasinger | Restricted Stock Units | D | 6,875 | - | 20,625 | D | M |
| 14 Mar, 2026 | Naimish Patel | Restricted Stock Units | D | 8,125 | - | 24,375 | D | M |
| 16 Mar, 2026 | Raju Prasad | Common Shares | D | 5,848 | $48.26 | 17,794 | D | S |
| 16 Mar, 2026 | Raju Prasad | Common Shares | D | 4,021 | $48.26 | 13,773 | D | S |
| 16 Mar, 2026 | Raju Prasad | Common Shares | D | 750 | $0.00 | 13,023 | D | G |
| 14 Mar, 2026 | Raju Prasad | Restricted Stock Units | D | 10,000 | - | 10,000 | D | M |
| 14 Mar, 2026 | Raju Prasad | Restricted Stock Units | D | 6,875 | - | 20,625 | D | M |
| 10 Mar, 2026 | James R. Kasinger | Common Shares | A | 5,500 | - | 90,615 | D | M |
| 10 Mar, 2026 | Samarth Kulkarni | Common Shares | A | 19,250 | - | 245,356 | D | M |
| 11 Mar, 2026 | Samarth Kulkarni | Common Shares | D | 9,798 | $52.80 | 235,558 | D | S |
| 11 Mar, 2026 | James R. Kasinger | Common Shares | D | 2,800 | $52.80 | 87,815 | D | S |